Literature DB >> 10893641

Intravesical oxyhemoglobin initiates bladder overactivity in conscious, normal rats.

R K Pandita1, H Mizusawa, K E Andersson.   

Abstract

PURPOSE: To investigate whether intravesical oxyhemoglobin, a nitric oxide scavenger, changes bladder activity in normal rats.
MATERIALS AND METHODS: Oxyhemoglobin was given intravesically at different concentrations to conscious, female Sprague-Dawley rats undergoing continuous cystometry.
RESULTS: Intravesical oxyhemoglobin increased bladder activity in a concentration-dependent way. At a concentration of 2.5 x 10-4 M (n = 8), micturition pressure (p <0. 01), basal pressure (p <0.01), and residual volume (p <0.05) increased, and bladder capacity (p <0.001) and micturition volume (p <0.001) decreased. The effect of oxyhemoglobin was reduced or abolished by L-arginine (200 mg./kg.-1), given intra-arterially near the bladder, and was enhanced by the guanylate cyclase inhibitor, ODQ (0.5 and 1 mg./kg.-1). The K+ channel opener, ZD6169 100 ng.ml. -1, given intravesically for 1 hour prior to instillation of oxyhemoglobin, reduced or completely prevented the bladder activity induced by oxyhemoglobin.
CONCLUSIONS: Intravesical oxyhemoglobin induces bladder overactivity, probably by interfering with nitric oxide (NO) generated in the urothelium or suburothelially. NO may be involved in the regulation of the threshold for afferent firing in the bladder.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10893641

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  25 in total

Review 1.  Bladder afferent signaling: recent findings.

Authors:  Anthony Kanai; Karl-Erik Andersson
Journal:  J Urol       Date:  2010-02-19       Impact factor: 7.450

Review 2.  Mechanisms of disease: involvement of the urothelium in bladder dysfunction.

Authors:  Lori A Birder; William C de Groat
Journal:  Nat Clin Pract Urol       Date:  2007-01

Review 3.  TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications.

Authors:  António Avelino; Francisco Cruz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-24       Impact factor: 3.000

Review 4.  Integrative control of the lower urinary tract: preclinical perspective.

Authors:  William C de Groat
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 5.  Cell biology and physiology of the uroepithelium.

Authors:  Puneet Khandelwal; Soman N Abraham; Gerard Apodaca
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-08

Review 6.  Changes in afferent activity after spinal cord injury.

Authors:  William C de Groat; Naoki Yoshimura
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

7.  Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells.

Authors:  Lori A Birder; Michele L Nealen; Susanna Kiss; William C de Groat; Michael J Caterina; Edward Wang; Gerard Apodaca; Anthony J Kanai
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

8.  Nitric oxide modulates bladder afferent nerve activity in the in vitro urinary bladder-pelvic nerve preparation from rats with cyclophosphamide induced cystitis.

Authors:  Yongbei Yu; William C de Groat
Journal:  Brain Res       Date:  2012-10-10       Impact factor: 3.252

9.  Activation of muscarinic receptors in rat bladder sensory pathways alters reflex bladder activity.

Authors:  F Aura Kullmann; Debra E Artim; Lori A Birder; William C de Groat
Journal:  J Neurosci       Date:  2008-02-20       Impact factor: 6.167

10.  Nitric oxide-mediated suppression of detrusor overactivity by arginase inhibitor in rats with chronic spinal cord injury.

Authors:  Kurumi Sasatomi; Shiro Hiragata; Minoru Miyazato; Michael B Chancellor; Sidney M Morris; Naoki Yoshimura
Journal:  Urology       Date:  2008-03-21       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.